Search Records

Research: Gap analyses to assess Canadian readiness for respiratory syncytial virus vaccines: Report from an expert retreat. Published on Canada Communicable Disease Report (CCDR), volume 46-4, April 2, 2020.

The list below includes all applications received by Health Canada for drugs and vaccines used for the COVID-19 pandemic. This list includes applications received under the interim order and those received under the Food and Drug Regulations. The current status of each application is also noted.

Drugs and vaccines that have been authorized by Health Canada for use in relation to the COVID-19 pandemic are listed here.

The list below includes all applications received by Health Canada for drugs and vaccines used for the COVID-19 pandemic. This list includes applications received under the interim order and those received under the Food and Drug Regulations. The current status of each application is also noted.

Drugs and vaccines that have been authorized by Health Canada for use in relation to the COVID-19 pandemic are listed here.

This Points to Consider document lays out a regulatory approach for updating authorised coronavirus vaccines should mutations at any time make them less efficacious due to insufficient cross-reactivity.

Sponsors of COVID-19-related drug and vaccine clinical trials can choose between 2 different processes: existing process outlined in the Food and Drug Regulations or process outlined in the new interim order for clinical trials for medical devices and drugs related to COVID-19.

"This dataset provides the cumulative number and percent of people who have received a COVID-19 vaccine in Canada by report week, number of doses, age group, sex, and jurisdiction. Variables include: Jurisdiction ID number Jurisdiction Report week Sex Age group Cumulative number vaccinated with...

"This dataset provides the cumulative number and percent of people in key populations who have received a COVID-19 vaccine in Canada, by number of doses and report week. Key populations are identified by the National Advisory Committee on Immunization and prioritized for early vaccination....

Research: Overview of the respiratory syncytial virus vaccine candidate pipeline in Canada. Published on Canada Communicable Disease Report (CCDR), volume 46-4, April 2, 2020.